Follow


Submissions from 2019

Efficacy of a stepped-care CBT-I approach for insomnia, Philip Cheng, Cynthia Fellman-Couture, R L. Atkinson, Christine V. Tonnu, Kenneth Moss, and Christopher L Drake

Comparative efficacy of digital CBT-I versus stepped-care CBT-I to reduce comorbid depression, Philip Cheng, Cynthia Fellman-Couture, R L. Atkinson, Christine V. Tonnu, Meeta Singh, and Christopher L Drake

Insomnia in late pregnancy: Characterizing phenotypes and identifying associated factors, Andrea Cuamatzi-Castelan, David A Kalmbach, R L. Atkinson, Roopina Sangha, Luisa Bazan, L M. O'Brien, L M. Swanson, Thomas Roth, and Christopher L Drake

Changes in use of sleep aids following digital cognitive behavioral therapy for insomnia, Christopher L Drake, Philip Cheng, Gabriel Tallent, R L. Atkinson, Andrea Cuamatzi-Castelan, and Luisa Bazan

Arousability of insomnia patients is not impacted by the orexin antagonist suvorexant (10 mg and 20 mg), Christopher L Drake, Andrea Cuamatzi-Castelan, David A Kalmbach, Philip Cheng, Thomas Roth, Meeta Singh, M K. Tran, Christine V. Tonnu, R L. Atkinson, and Cynthia Fellman-Couture

Insomniacs in late pregnancy are clinically depressed: Exploring the role of nocturnal rumination, David A Kalmbach, Andrea Cuamatzi-Castelan, Christine V. Tonnu, Roopina Sangha, L M. O'Brien, L M. Swanson, Thomas Roth, and Christopher L Drake

Are people with severe insomnia able to discontinue hypnotics after chronic use?, Gail Koshorek, Jelena Verkler, Dana Withrow, Thomas Roth, and Timothy Roehrs

Effects of suvorexant on sleep in fibromyalgia, Gail Koshorek, Jelena Verkler, Dana Withrow, Thomas Roth, and Timothy Roehrs

Treatment of obstructive sleep apnea with positive airway pressure to improve cognitive function in mild cognitive impairment, Beth McLellan, Virginia Skiba, Marina Novikova, Lonni R Schultz, and Aarushi Suneja

Pharmacokinetics and dose proportionality of FT218, an investigational controlled release formulation of sodium oxybate for once nightly dosing, D Monteith, J Grassot, C Castellan, and Thomas Roth

Pharmacokinetics and formulation selection of FT218, an investigational controlledrelease sodium oxybate formulation designed for once nightly dosing, D Monteith, J Grassot, C Castellan, and Thomas Roth

Lemborexant treatment for insomnia in phase 3: Impact on disease severity, Thomas Roth, R Rosenberg, P Murphy, J Yardley, D Kumar, K Pinner, C Perdomo, and M Moline

Polysomnography in insomnia disorder, Jelena Verkler, Gail Koshorek, Thomas Roth, and Timothy Roehrs

Effects of suvorexant on pain sensitivity in fibromyalgia, Dana Withrow, Jelena Verkler, Gail Koshorek, Thomas Roth, and Timothy Roehrs

Submissions from 2018

Efficacy of Cognitive Behavioral Therapy for Insomnia on Post-Menopausal Quality of Life, JT Arnedt, Philip Cheng, Cynthia Fellman-Couture, G Tallent, David A Kalmbach, Meeta Singh, Thomas Roth, and Christopher L Drake

Comparison of Idiopathic Interstitial Pneumonia and Connective Tissue Disease Related Interstitial Lung Disease by Physiologic and Functional Testing Parameters, SK Avasarala, Sarah Gorgis, Mohammed Dabbagh, A Saeed, C Gondolfo, N Garza, Jeffrey H. Jennings, and Krishna Thavarajah

Digital Cognitive Behavioral Therapy for Insomnia Reduces Incident Depression at Oneyear Follow-Up, Philip Cheng, G Tallent, A Luik, Edward L Peterson, K Tran, Brian Ahmedani, D Adler, Thomas Roth, and Christopher L Drake

Applicaiton of Mathematical Modeling for Faster Circadian Tntrainment, Philip Cheng, O Walch, and Christopher L Drake

Using mathematical modeling to predict circadian phase in night shift workers, Philip Cheng, O Walch, K Tran, Andrea Cuamatzi-Castelan, and Christopher L Drake

Using Mathematical Modeling to Predict Circadian Phase in Night Shift Workers, Philip Cheng, O Walch, K Tran, Andrea Cuamatzi-Castelan, and Christopher L Drake

Long-term Efficacy of the Sleep to Prevent Evolving Affective Disorders (SPREAD) Trial as an Internet-based Treatment for Insomnia, Andrea Cuamatzi-Castelan, Philip Cheng, Cynthia Fellman-Couture, G Tallent, K Tran, CA Espie, Christine LM Joseph, Timothy Roehrs, and Christopher L Drake

Efficacy of SM-1 in a Transient Insomnia Model, T Dahl, Thomas Roth, M Ahmad, and L Chen

The Pharmacokinetics and Pharmacodynamics of SM-1, T Dahl, Thomas Roth, M Scheinin, J Suopanki-Lalowski, M Valge, A Puhakka, H Mikola, Z Lovró, A Meierjohann, L Vuorilehto, and L Chen

Examining the Effects of Slow-Wave Activity Disruption on Waking EEG Theta Activity, J Goldschmied, Philip Cheng, R Armitage, and P Deldin

Management of Ehlers-Danlos Related OSA with Home Sleep Testing and Auto-CPAP, J Hogaboam, K Moss, and L Bazan

Inability to Discontinue Chronic Hypnotic Use, Gail Koshorek, D Withrow, Thomas Roth, and Timothy Roehrs

The Impact of Treating Insomnia upon Functional Health, Psychological Wellbeing and Sleep-Related Quality of Life: A Randomised Controlled Trial with Mediation Analysis, A Luik, R Emsley, SD Kyle, C Gordon, Christopher L Drake, A Marsden, and CA Espie

Relationship Between Efficacy Endpoints and Measures of Functional Status and Health-Related Quality of Life (HRQoL) in Obstructive Sleep Apnea patients Treated for Excessive Sleepiness, SD Mathias, RD Crosby, Christopher L Drake, M Bron, S Bujanover, D Menno, and KF Villa

Stress-Related Sleep Reactivity Predicts Peri-Partum Insomnia, Psychopathology and Suicidality, L Palagini, U Moretto, M Novi, D Caruso, and Christopher L Drake

Markers for Hypnotic Abuse Liability: Cortisol in Insomnia?, Timothy Roehrs, Gail Koshorek, D Withrow, and Thomas Roth

Effectiveness of Recruiting Type 1 Narcolepsy Patients via Internet Based Pre-Selection System, Thomas Roth, S O'Daly, M Fenton, S Dowd, N Cassidy, J Allen, D Monteith, and S Klassen

Treatment of Obstructive Sleep Apnea with Positive Airway Pressure in Mild Cognitive Impairment, Aarushi Suneja, Virginia Skiba, Marina Novikova, Lonni Schultz, and Beth McLellan

Impact of Behavioral Insomnia Treatments on Quality of Life in Post-menopausal Women, G Tallent, Philip Cheng, Cynthia Fellman-Couture, Christine V. Tonnu, K Moss, T Arnedt, and Christopher L Drake

Impact of Behavioral Insomnia Treatment on Post-Menopausal Female Sexual Functioning, Christine V. Tonnu, Philip Cheng, D Kalmbach, Cynthia Fellman-Couture, G Tallent, J Arnedt, Meeta Singh, and Christopher L Drake

Insomnia and Stress: Associations with Mental Resilience and Mood, JC Verster, L Palagini, M Mackus, AJ Van De Loo, J Garssen, and Thomas Roth

Self-Reported Sleep During Discontinuation of Chronic Hypnotic Use, D Withrow, Gail Koshorek, Thomas Roth, and Timothy Roehrs

Submissions from 2017

Clinical Profile of Suvorexant for the Treatment of Insomnia over 3 Months in Women and Men: Subgroup Analysis of Pooled Phase-3 Data, WJ Herring, KM Connor, E Snyder, DB Snavely, Y Zhang, J Hutzelmann, D Matzura-Wolfe, RM Benca, AD Krystal, JK Walsh, C Lines, Thomas Roth, and D Michelson